Mylan Institutional LLC Recall: Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL v
Mylan Institutional LLC Recall: Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL v is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Mylan Institutional LLC; Product: Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton,
| Recalling firm | Mylan Institutional LLC |
|---|---|
| Product | Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02 |
| Reason for recall | Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide within the United States |
| Recall initiated | 20210503 |
| Recall number | D-0601-2021 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →